Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Edirne
Clinical trial register · Turkey

Clinical Trials in Edirne, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca17 Eli Lilly and Company17 Merck Sharp & Dohme LLC14 Hoffmann-La Roche12 Trakya University10
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Edirne

145 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
Vividion Therapeutics, Inc.
Phase 2
140
Bilkent Çankaya, Kadıköy, Edirne, Gaziantep, Istanbul, Samsun, Yenimahalle
2026-09-11
Recruiting
Trakya University
Observational
400
Edirne
2026-07-06
Recruiting
Novo Nordisk A/S
Phase 3
400
Bahçelievler/İstanbul, Çankaya/Ankara, Edirne, Fatih/İstanbul, Yuregir/Adana, Yıldırım/Bursa
2026-04-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Sıhhiye, Adana, Ankara, Edirne, Istanbul, Izmir
2026-04-09
Not yet open
Trakya University
Not applicable
34
Edirne
2026-04-01
Recruiting
Trakya University
Observational
200
Edirne
2026-03-15
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Ankara, Edirne, Kadiköy/Istanbul, Manisa, Sakarya
2026-03-13
Recruiting
Early Effects of Orthognathic Surgery on Periodontal Phenotype: A 6-Month Prospective Clinical and Radiographic Evaluation
NCT07349056Gingival Biotype, Gingival Phenotype, Buccal Bone Thickness, Recession, Gingival
Trakya University
Observational
100
Edirne, Kocaeli
2026-02-23
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Izmir, Karsiyaka, Adana, Ankara, Antalya, Bursa, Edirne, Istanbul
2026-01-02
Not yet open
Trakya University
Not applicable
96
Edirne
2025-12-29
Recruiting
Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder
NCT07327775Fibromyalgia Syndrome, Disease Burden, Attention-Deficit/Hyperactivity Disorder
Sultan 1. Murat State Hospital
Observational
100
Edirne
2025-12-26
Recruiting
Eli Lilly and Company
Phase 3
800
Adana, Ankara, Aydin, Edirne, Istanbul, Izmir, Mersin
2025-12-22
Active, closed
Taiho Oncology, Inc.
Phase 3
360
Adana, Yüreğir, Ankara, Etlik, Sur, Edirne, Gaziantep, Şehitkamil
2025-12-22
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Adana, Adapazarı, Ankara, Antalya, Diyarbakır, Edirne, Gaziantep, Istanbul
2025-12-12
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Adana, Ankara, Antalya, Bornova, Edirne, Gaziantep, Pendik, Sakarya
2025-11-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Seyhan, Altindağ, Ankara, Edirne, Istanbul
2025-10-08
Recruiting
TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%
NCT07279402NSCLC Stage IV, PD-L1 Gene Mutation, Atezolizumab, Real World Study
Antalya Training and Research Hospital
Observational
150
Adana, Afyonkarahisar, Ankara, Antalya, Aydin, Diyarbakır, Edirne, Gaziantep
2025-09-15
Active, closed
Trakya University
Observational
3
Edirne
2025-09-09
Recruiting
Takeda
Phase 3
150
Mamak, Efeler, Edirne, Sakarya
2025-08-14
Recruiting
Kedrion S.p.A.
Phase 3
40
Ankara, Yenimahalle, Edirne, Izmir, Mersin, Adapazarı
2025-08-13
Recruiting
Merck Sharp & Dohme LLC
Phase 2
250
Adana, Ankara, Edirne, Istanbul
2025-08-11
Recruiting
Celcuity Inc
Phase 3
1,180
Adana, Ankara, Diyarbakır, Edirne, Istanbul, İzmit, Konya, Mezitli
2025-07-24
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Edirne, Istanbul, Izmir
2025-07-22
Recruiting
Effect of Music and Warm Foot Bath Therapy on Pregnancy-Related Anxiety, Blood Pressure and Quality of Life
NCT07064733Primigravida Women, Music Therapy, Blood Pressure Monitoring, Quality of Life
Kırklareli University
Not applicable
144
Edirne
2025-06-06
Recruiting
AstraZeneca
Phase 3
15,100
Afyonkarahisar, Ankara, Antalya, Çanakkale, Edirne, Istanbul, Izmir, Kayseri
2025-06-04
Not yet open
Trakya University
Not applicable
66
Edirne
2025-05-15
Recruiting
Eli Lilly and Company
Phase 3
700
Adana, Adapazarı, Ankara, Antalya, Edirne, Gaziantep, Istanbul, Izmir
2025-03-27
Active, closed
Immutep S.A.S.
Phase 3
756
Adana, Ankara, Bursa, Cevizli, Edirne, Istanbul, Sakarya
2025-03-21
Active, closed
THE RELATIONSHIP BETWEEN CARDIAC RESYNCHRONİZATION THERAPY RESPONSE IN HEART FAILURE PATIENTS AND YKL-40 LEVELS
NCT07469137Hearth Failure With Reduced Ejection Fraction (HFrEF), Cardiac Resynchronisation Therapy (CRT), Left Branch Bundle Block
Trakya University
Observational
51
Edirne
2025-03-01
Recruiting
Trakya University
Not applicable
26
Edirne
2025-03-01
Recruiting
Takeda
Phase 3
171
Mamak, Efeler, Edirne, Sakarya
2025-02-27
Recruiting
BioNTech SE
Phase 3
621
Adana, Ankara, Antalya, Edirne, Istanbul, Izmir, Kocaeli, Mamak
2025-02-03
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Adana, Ankara, Antalya, Edirne, Istanbul, Konya, Sakarya
2024-12-12
Recruiting
AstraZeneca
Phase 3
1,160
Ankara, Antalya, Edirne, Izmir, Seyhan
2024-11-27
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Adana, Ankara, Diyarbakır, Edirne, Erzurum, Kayseri, Kocaeli, Sakarya
2024-11-22
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Istanbul, Ankara, Antalya, Edirne
2024-07-19
Recruiting
Amgen
Phase 3
450
Adana, Ankara, Edirne, Istanbul, Izmir, Konya, Malatya
2024-07-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Bornova, Ankara, Antalya, Edirne, Istanbul, Kocaeli, Samsun
2024-07-16
Active, closed
PVP-Guided Decongestive Therapy in HF 2
NCT06495892Heart Failure, Congestion, Congestive Heart Failure
Başakşehir Çam & Sakura City Hospital
Phase 4
650
Ankara, Antalya, Edirne, Erzurum, Eskişehir, Istanbul, Izmir, Kahramanmaraş
2024-07-01
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Ankara, Istanbul, Eskişehir, Afyonkarahisar, Antalya, Bursa, Edirne, Kayseri
2024-06-25
Active, closed
Eli Lilly and Company
Phase 3
10,000
Afyonkarahisar, Ankara, Antalya, Bornova, Çorum, Edirne, Eskişehir, Gaziantep
2024-04-30
Recruiting
CSL Behring
Phase 2/3
3,110
Ankara, Antalya, Atakum, Bakırköy, Bornova, Edirne, Gaziantep, İzmit
2024-04-27
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
43
Altındağ, Ankara, Edirne, Erzurum, Istanbul
2024-04-02
Active, closed
Novo Nordisk A/S
Phase 3
673
Eskişehir, Adana, Afyonkarahisar, Ankara, Bursa, Edirne, Istanbul, Kayseri
2024-04-01
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
DrugAdagrasib
Mirati Therapeutics Inc.
Phase 2
200
Ankara, Istanbul, Edirne, Izmir
2024-02-01
Active, closed
BicycleTx Limited
Phase 2
375
Edirne, Istanbul, Izmir, Kocaeli
2024-01-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Bornova, Ankara, Antalya, Edirne, Istanbul, Kocaeli, Mersin, Samsun
2023-12-31
Active, closed
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
NCT05973773Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
DrugZipalertinib
Taiho Oncology, Inc.
Phase 3
285
Adana, Ankara, Edirne, Etlik, Istanbul, Çankaya
2023-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Ankara, Antalya, Edirne, Istanbul, Izmir, Samsun
2023-12-13
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
756
Ankara, Edirne, Istanbul, Izmir, Kocaeli, Konya, Malatya
2023-11-15
Active, closed
Incyte Corporation
Phase 2
73
Adana, Ankara, Edirne, Istanbul, Kocaeli
2023-10-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Istanbul- Fatih, Ankara, Antalya, Edirne, Eskişehir, Istanbul, Kocaeli
2023-10-25
Active, closed
Incyte Corporation
Phase 2
63
Adana, Ankara, Edirne
2023-10-09
Active, closed
Hoffmann-La Roche
Phase 3
687
Adana, Ankara, Edirne, Kar?iyaka
2023-09-14
Active, closed
Novartis Pharmaceuticals
Phase 2
41
Aydin, Istanbul, Edirne, Izmir, Kocaeli
2023-08-16
Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
NCT05967689Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
DrugZipalertinib
Taiho Oncology, Inc.
Phase 2
220
Esenyurt, Adana, Edirne, Istanbul
2023-07-31
Active, closed
OncoC4, Inc.
Phase 3
630
Adana, Ankara, Antalya, Edirne, Fatih, Istanbul, Izmir
2023-06-28
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Ankara, Çankaya, Edirne, Istanbul, Izmir, Kayseri, Yenimahalle
2023-06-22
Recruiting
Hoffmann-La Roche
Phase 3
420
Ankara, Diyarbakır, Edirne, Istanbul, Izmir, Kadiköy, Seyhan, Sihhiye/Ankara
2023-06-07
Recruiting
Tanta University
Not applicable
128
Edirne
2023-05-18
Active, closed
Hoffmann-La Roche
Phase 2
204
Adana, Ankara, Edirne, Izmir, Kadiköy
2023-04-13
Active, closed
Pfizer
Phase 3
624
Altindağ, Istanbul, Izmir, Adana, Ankara, Antalya, Edirne, Samsun
2023-03-03
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Ankara, Istanbul, Eskişehir, Bursa, Adana, Afyonkarahisar, Edirne, Izmir
2023-03-01
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Ankara, Capa-ISTANBUL, Antalya, Adana, Bornova-IZMIR, Edirne
2023-02-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Ankara, Edirne, Istanbul, Izmir, Mersin
2023-02-06
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Yüreğir, Sur, İzmit, Gaziantep, Ankara, Edirne, Istanbul
2023-01-16
Active, closed
AstraZeneca
Phase 3
1,350
Adana, Ankara, Edirne, Istanbul, Izmir
2022-12-29
Active, closed
Dizal Pharmaceuticals
Phase 3
324
Ankara, Edirne, Istanbul, Kadıköy, Konya
2022-12-13
Active, closed
Gilead Sciences
Phase 3
1,021
Ankara, Edirne, Fatih, Istanbul, Kaakaekmece, Malatya
2022-10-12
Active, closed
Eli Lilly and Company
Phase 3
8,000
Adana, Adapazarı, Altindağ, Ankara, Antalya, Bursa, Diyarbakır, Edirne
2022-10-04
Recruiting
AstraZeneca
Phase 2
454
Ankara, Cordaleo, Edirne, Kadıkoy/Istanbul, Konya, Pamukkale, Samsun
2022-09-06
Active, closed
Trakya University
Observational
65
Edirne
2022-09-01
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Adana, Ankara, Edirne, Istanbul, Izmir, Samsun
2022-08-05
Active, closed
AstraZeneca
Phase 3
341
Adana, Ankara, Edirne, Istanbul, Izmir
2022-08-03
Active, closed
Gilead Sciences
Phase 3
443
Adana, Ankara, Edirne, Istanbul, Izmir, Sariyer, Şişli
2022-07-25
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
DrugsZilovertamab vedotin·Nemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
189
Stanbul, Bornova, Ankara, Edirne, Samsun
2022-07-21
Active, closed
Gilead Sciences
Phase 3
623
Adana, Ankara, Edirne, Istanbul, Izmir, Sariyer
2022-07-20
Active, closed
Hoffmann-La Roche
Phase 3
922
Adana, Ankara, Diyarbakır, Edirne, Erzurum, Istanbul, Izmir, İzmit
2022-07-18
Active, closed
Merck Sharp & Dohme LLC
Phase 2
60
Stanbul, Ankara, Edirne
2022-07-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Yüreğir, Istanbul, Izmir, İzmit, Gaziantep, Ankara, Diyarbakır, Edirne
2022-07-14
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Ankara, Antalya, Bursa, Edirne, Erciyes, Istanbul, Kocaeli
2022-05-30
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
372
Ankara, Edirne, Istanbul, Izmir
2022-05-03
Active, closed
Eli Lilly and Company
Phase 3
925
Stanbul, Izmir, Karsiyaka, Adana, Ankara, Diyarbakır, Edirne, Istanbul, Malatya
2022-04-14
Active, closed
AstraZeneca
Phase 3
1,035
Adana, Edirne, Izmir, Şahinbey, Yüreğir
2022-03-25
Active, closed
Eli Lilly and Company
Phase 3
368
Cordaleo, Meram, Adana, Ankara, Diyarbakır, Edirne, Istanbul, Malatya
2022-03-11
Active, closed
AstraZeneca
Phase 3
791
Adapazarı, Ankara, Antalya, Çankaya, Edirne, Istanbul, Izmir, Konya
2022-02-18
Active, closed
Eli Lilly and Company
Phase 3
152
Bornova, Izmir, Karsiyaka, Adana, Ankara, Antalya, Bursa, Diyarbakır, Edirne
2021-12-20
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Ankara, Edirne, Izmir, Seyhan, Trabzon, Yenimahalle
2021-12-02
Active, closed
Hoffmann-La Roche
Phase 3
660
Ankara, Bursa, Denizli, Diyarbakır, Edirne, Istanbul, Izmir, İzmit
2021-11-18
Active, closed
Gilead Sciences
Phase 3
603
Ankara, Bursa, Dikimevi- Ankara, Edirne, Istanbul, Kadıköy, Sariyer, Yenimahalle
2021-11-17
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Adana, Ankara, Edirne, Istanbul, Izmir
2021-11-17
Active, closed
Novartis Pharmaceuticals
Phase 3
153
Istanbul, Edirne, Ankara, Adana
2021-11-15
Active, closed
AstraZeneca
Phase 3
148
Adana, Ankara, Cordaleo, Edirne, Istanbul, Izmir, Kazımkarabekir
2021-10-28
Active, closed
AstraZeneca
Phase 3
454
Çankaya, Edirne, Izmir, Kadıkoy/Istanbul
2021-10-28
Active, closed
Eli Lilly and Company
Phase 3
874
Stanbul, Üsküdar / Stanbul, Adana, Ankara, Antalya, Diyarbakır, Edirne, Istanbul
2021-10-04
Recruiting
International Rare And Severe Psoriasis Expert Network
NCT04359394Pustular Psoriasis (PP)
University Hospital, Basel, Switzerland
Observational
180
Antalya, Edirne
2021-09-22
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Sariçam, Ankara, Antalya, Edirne, Istanbul, Izmir, Kocaeli, Samsun
2021-08-27
Active, closed
AstraZeneca
Phase 3
712
Adana, Ankara, Antalya, Cordaleo, Edirne, Istanbul
2021-08-05
Active, closed
Daiichi Sankyo
Phase 3
490
Adana, Edirne, Istanbul, Malatya
2021-05-21
Active, closed
Pfizer
Phase 3
599
Adana, Ankara, Edirne, Istanbul, Malatya
2021-05-12
Active, closed
Hoffmann-La Roche
Observational
800
Adana, Ankara, Antalya, Denizli, Edirne, Istanbul, Izmir, Malatya
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Adana, Ankara, Antalya, Bornova, ?zm?r, Diyarbakır, Edirne, Istanbul, Izmir
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
761
Adana, Ankara, Bakirkoy / Istanbul, Cordaleo, Edirne, Istanbul, Samsun
2021-05-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Ankara, Edirne, Istanbul, Izmir
2021-04-14
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Ankara, Antalya, Edirne, Gaziantep, Izmir, Kayseri, Kocaeli, Mersin
2021-04-09
Active, closed
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
NCT04736173Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer, Squamous Non Small Cell Lung Cancer, Lung Cancer
DrugsDomvanalimab·Zimberelimab·Pemetrexed·Paclitaxel
Arcus Biosciences, Inc.
Phase 2
169
Adana, Ankara, Edirne, Istanbul, Kocaeli
2021-02-08
Active, closed
AstraZeneca
Phase 1/2
245
Ankara, Edirne, Istanbul, Izmir
2020-12-28
Active, closed
Daiichi Sankyo
Phase 3
1,600
Ankara, Edirne, Istanbul, Izmir
2020-12-04
Active, closed
Bayer
Phase 4
654
Adana, Ankara, Edirne, Gaziantep, Istanbul, Izmir, Kayseri, Mersin
2020-11-09
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Adana, Ankara, Edirne, Istanbul, Izmir
2020-10-13
Active, closed
Hoffmann-La Roche
Phase 3
992
Ankara, Edirne, Istanbul, Izmir, İzmit, Malatya, Samsun
2020-10-09
Active, closed
Acerta Pharma BV
Phase 3
611
Ankara, Balçova, Edirne, Izmir, Kayseri, Mersin, Samsun, Trabzon
2020-10-08
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Adana, Ankara, Edirne, Istanbul, Izmir, Konya
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Adana, Ankara, Bursa, Edirne, Istanbul, Izmir, Sakarya, Samsun
2020-09-23
Active, closed
Eli Lilly and Company
Phase 3
996
Ankara, Antalya, Bursa, Edirne, Eskişehir, Antakya, Istanbul, Istanbul- Fatih
2020-06-22
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Ankara, Antalya, Edirne, Istanbul, Konya, Malatya
2020-03-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Ankara, Edirne, Istanbul, Izmir
2020-02-27
Active, closed
Amgen
Phase 3
145
Ankara, Denizli, Edirne, Istanbul, Izmir, Kocaeli, Konya, Malatya
2020-02-26
Active, closed
Eli Lilly and Company
Phase 3
261
Bornova, Adana, Ankara, Antalya, Diyarbakır, Edirne, Istanbul, Izmir
2020-02-17
Active, closed
Takeda
Phase 3
354
Yüreğir, Kadıköy, Bornova, Karaman, Ankara, Edirne
2020-01-10
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Ankara, Capa-ISTANBUL, Adana, Edirne, Izmir, Samsun
2019-11-13
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Ankara, Edirne, Istanbul, Izmir, Kocaeli, Mersin
2019-09-26
Active, closed
BeOne Medicines
Phase 3
510
Ankara, Edirne, Istanbul, Mersin
2019-08-20
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Adana, Ankara, Antalya, Edirne, Istanbul, Izmir, Kocaeli
2019-01-25
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Konya, Adana, Ankara, Antalya, Edirne, Istanbul, Izmir
2018-12-12
Active, closed
AstraZeneca
Phase 3
407
Adana, Ankara, Edirne, Istanbul, Konya, Malatya
2018-11-27
Active, closed
AstraZeneca
Phase 3
1,063
Ankara, Cordaleo, Edirne, Istanbul, Izmir
2018-11-16
Active, closed
AstraZeneca
Phase 3
730
Adana, Ankara, Antalya, Edirne, Istanbul, Izmir, Konya, Samsun
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Adana, Adapazarı, Ankara, Edirne, Istanbul, Izmir
2018-09-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Üsküdar /Istanbul, Balçova, Adana, Ankara, Antalya, Edirne, Erzurum, Istanbul
2018-08-21
Active, closed
Exelixis
Phase 3
837
Istanbul, Ankara, Edirne, Malatya
2018-06-10
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Adana, Ankara, Aydin, Edirne, Istanbul, Izmir, Kocaeli, Konya
2018-04-05
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Adana, Antalya, Edirne, Istanbul, Kar??yaka, Sihhiye/Ankara
2017-09-22
Active, closed
Hoffmann-La Roche
Phase 3
382
Edirne, Istanbul, S?hhiye, Ankara
2017-09-20
Active, closed
Eli Lilly and Company
Phase 3
5,637
Istanbul- Fatih, Üsküdar/stanbul, Bornova, Izmir, Karsiyaka, Ankara, Adana, Antalya, Edirne
2017-07-12
Active, closed
AstraZeneca
Phase 3
987
Ankara, Edirne, Istanbul, Izmir
2017-03-27
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Edirne
2016-06
Active, closed
Eli Lilly and Company
Phase 2
309
Adana, Ankara, Antalya, Edirne, Istanbul
2016-05-19
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Ankara, Edirne, Istanbul, Izmir, Mersin
2015-11-27
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Adana, Ankara, Edirne, Istanbul, Izmir, Kayseri, Kocaeli
2015-11-19
Active, closed
AstraZeneca
Phase 3
1,126
Ankara, Edirne, Izmir
2015-11-02
Active, closed
Eli Lilly and Company
Phase 3
545
Bornova, Adana, Edirne, Malatya
2015-05-06
Active, closed
Eli Lilly and Company
Phase 3
493
Ankara, Edirne, Malatya
2014-11-06
Active, closed
Eli Lilly and Company
Phase 3
453
Ankara, Antalya, Edirne, Istanbul, Izmir
2014-10-03
Recruiting
University Hospital, Gasthuisberg
Observational
5,000
Edirne
2005-08
Rows per page Showing 1–145 of 145
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/edirne

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 145 of those studies with a site in Edirne.

How many clinical trials are recruiting in Edirne?

42 of the 145 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 100 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Edirne), 145 studies
PhaseStudiesRecruitingShare
Phase 31022370.3%
Phase 217611.7%
Observational1177.6%
Not applicable634.1%
Phase 2/3533.4%
Phase 1/2201.4%
Phase 4201.4%

Most active sponsors

Lead sponsors with the most studies (Edirne)
Lead sponsorStudiesRecruiting
AstraZeneca173
Eli Lilly and Company174
Merck Sharp & Dohme LLC145
Hoffmann-La Roche121
Trakya University104
Janssen Research & Development, LLC91
Novo Nordisk A/S61
Gilead Sciences40
Bristol-Myers Squibb32
Novartis Pharmaceuticals30
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.